A detailed history of Integrated Advisors Network LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Integrated Advisors Network LLC holds 43,610 shares of AZN stock, worth $2.93 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
43,610
Previous 29,750 46.59%
Holding current value
$2.93 Million
Previous $2.32 Million 46.47%
% of portfolio
0.16%
Previous 0.12%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$76.67 - $87.62 $1.06 Million - $1.21 Million
13,860 Added 46.59%
43,610 $3.4 Million
Q2 2024

Aug 09, 2024

BUY
$66.81 - $80.83 $1.54 Million - $1.86 Million
23,005 Added 341.07%
29,750 $2.32 Million
Q1 2024

May 03, 2024

BUY
$61.03 - $69.57 $14,158 - $16,140
232 Added 3.56%
6,745 $456,000
Q4 2023

Feb 26, 2024

BUY
$61.89 - $69.28 $21,166 - $23,693
342 Added 5.54%
6,513 $438,000
Q3 2023

Nov 16, 2023

SELL
$64.85 - $71.7 $1,037 - $1,147
-16 Reduced 0.26%
6,171 $417,000
Q2 2023

Jul 14, 2023

SELL
$69.91 - $75.81 $19,085 - $20,696
-273 Reduced 4.23%
6,187 $442,000
Q1 2023

May 05, 2023

SELL
$63.15 - $71.6 $909,044 - $1.03 Million
-14,395 Reduced 69.02%
6,460 $448,000
Q4 2022

Feb 02, 2023

BUY
$54.21 - $70.44 $1.13 Million - $1.47 Million
20,855 New
20,855 $1.41 Million
Q3 2022

Nov 07, 2022

SELL
$53.02 - $135.75 $3.14 Million - $8.04 Million
-59,260 Reduced 74.78%
19,985 $1.1 Million
Q2 2022

Aug 12, 2022

BUY
$59.26 - $71.14 $118,223 - $141,924
1,995 Added 2.58%
79,245 $5.24 Million
Q1 2022

May 02, 2022

BUY
$55.72 - $67.12 $100,630 - $121,218
1,806 Added 2.39%
77,250 $5.12 Million
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $35,599 - $42,063
659 Added 0.88%
75,444 $4.4 Million
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $3.28 Million - $3.59 Million
59,025 Added 374.52%
74,785 $4.49 Million
Q2 2021

Aug 06, 2021

SELL
$48.42 - $60.18 $164,385 - $204,311
-3,395 Reduced 17.72%
15,760 $944,000
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $1.39 Million - $1.6 Million
-29,439 Reduced 60.58%
19,155 $952,000
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $442,696 - $529,374
-9,124 Reduced 15.81%
48,594 $2.43 Million
Q3 2020

Nov 09, 2020

BUY
$53.07 - $61.1 $3.06 Million - $3.53 Million
57,718 New
57,718 $3.16 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.